Australia RNAI Therapeutics Market (2025-2031) | Forecast, Outlook, Size & Revenue, Competitive Landscape, Segmentation, Analysis, Industry, Companies, Growth, Share, Trends, Value

Market Forecast By Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, Others), By End-User (Diagnostic Laboratories, Research and Academic Laboratories, Hospitals) And Competitive Landscape
Product Code: ETC6189619 Publication Date: Sep 2024 Updated Date: May 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Australia Rnai Therapeutics Market Overview

The RNAi therapeutics market in Australia is witnessing growth with increasing interest in gene silencing approaches to treat chronic and genetic diseases. Research into RNAi-based therapies, particularly for liver and neurological conditions, is well-supported by the country`s strong biomedical research capabilities. Challenges such as off-target effects and delivery mechanisms remain areas of active investigation.

Trends of the market

RNAi therapeutics in Australia are advancing from research to clinical phases, with emphasis on treating rare and chronic diseases. The market is supported by the Australian Government’s Medical Research Future Fund (MRFF) and partnerships with international pharmaceutical companies. Increasing patent activity in RNAi delivery systems also underscores a growing innovation pipeline.

Challenges of the market

Australia’s RNAi therapeutics market faces barriers such as difficulties in achieving efficient and targeted gene silencing without triggering immune responses. Additionally, limited local manufacturing infrastructure and dependency on international suppliers for specialized reagents and delivery platforms increase costs and logistics complexity. Intellectual property issues also pose risks in this fast-evolving landscape.

Investment opportunities in the Market

With increasing clinical adoption and regulatory approvals, RNAi therapeutics offer promising investment avenues. Companies focused on silencing disease-causing genes using siRNA or miRNA hold potential, particularly in metabolic, genetic, and cancer-related disorders. Investors can benefit from IP licensing and therapeutic pipeline development.

Government Policy of the market

For RNAi therapeutics, the Australian government has adopted a proactive policy stance, aligning with global trends in gene silencing technologies. The TGA provides guidance on the classification and approval of RNAi-based treatments. Incentives for biopharmaceutical research and innovation, including co-investments in research infrastructure, further drive the growth of the RNAi therapeutics space.

Key Highlights of the Report:

  • Australia RNAI Therapeutics Market Outlook
  • Market Size of Australia RNAI Therapeutics Market, 2024
  • Forecast of Australia RNAI Therapeutics Market, 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Revenues & Volume for the Period 2021- 2031
  • Australia RNAI Therapeutics Market Trend Evolution
  • Australia RNAI Therapeutics Market Drivers and Challenges
  • Australia RNAI Therapeutics Price Trends
  • Australia RNAI Therapeutics Porter's Five Forces
  • Australia RNAI Therapeutics Industry Life Cycle
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Intradermal Injections for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Pulmonary Delivery for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Intravenous Injections for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Intraperitoneal Injections for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By End-User for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Diagnostic Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Research and Academic Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of Australia RNAI Therapeutics Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Australia RNAI Therapeutics Import Export Trade Statistics
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-User
  • Australia RNAI Therapeutics Top Companies Market Share
  • Australia RNAI Therapeutics Competitive Benchmarking By Technical and Operational Parameters
  • Australia RNAI Therapeutics Company Profiles
  • Australia RNAI Therapeutics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Australia RNAI Therapeutics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Australia RNAI Therapeutics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia RNAI Therapeutics Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Australia RNAI Therapeutics Market - Industry Life Cycle

3.4 Australia RNAI Therapeutics Market - Porter's Five Forces

3.5 Australia RNAI Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.6 Australia RNAI Therapeutics Market Revenues & Volume Share, By End-User, 2021 & 2031F

4 Australia RNAI Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Australia RNAI Therapeutics Market Trends

6 Australia RNAI Therapeutics Market, By Types

6.1 Australia RNAI Therapeutics Market, By Route of Administration

6.1.1 Overview and Analysis

6.1.2 Australia RNAI Therapeutics Market Revenues & Volume, By Route of Administration, 2021- 2031F

6.1.3 Australia RNAI Therapeutics Market Revenues & Volume, By Intradermal Injections, 2021- 2031F

6.1.4 Australia RNAI Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F

6.1.5 Australia RNAI Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F

6.1.6 Australia RNAI Therapeutics Market Revenues & Volume, By Intraperitoneal Injections, 2021- 2031F

6.1.7 Australia RNAI Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.2 Australia RNAI Therapeutics Market, By End-User

6.2.1 Overview and Analysis

6.2.2 Australia RNAI Therapeutics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.2.3 Australia RNAI Therapeutics Market Revenues & Volume, By Research and Academic Laboratories, 2021- 2031F

6.2.4 Australia RNAI Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F

7 Australia RNAI Therapeutics Market Import-Export Trade Statistics

7.1 Australia RNAI Therapeutics Market Export to Major Countries

7.2 Australia RNAI Therapeutics Market Imports from Major Countries

8 Australia RNAI Therapeutics Market Key Performance Indicators

9 Australia RNAI Therapeutics Market - Opportunity Assessment

9.1 Australia RNAI Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.2 Australia RNAI Therapeutics Market Opportunity Assessment, By End-User, 2021 & 2031F

10 Australia RNAI Therapeutics Market - Competitive Landscape

10.1 Australia RNAI Therapeutics Market Revenue Share, By Companies, 2024

10.2 Australia RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All